Synthesis of Hydroxy-α-sanshool

postprin

Magneto-optical properties of multilayer graphenes

The magneto-optical absorption properties of graphene multilayers are theoretically studied. It is shown that the spectrum can be decomposed into sub-components effectively identical to the monolayer or bilayer graphene, allowing us to understand the spectrum systematically as a function of the layer number. Odd-layered graphenes always exhibit absorption peaks which shifts in proportion to sqrt(B), with B being the magnetic field, due to the existence of an effective monolayer-like subband. We propose a possibility of observing the monolayer-like spectrum even in a mixture of multilayer graphene films with various layers numbers.Comment: 9 pages, 7 figure

Fertility and Forage Yield of Sorghum X Sudangrass Hybrids in A1 and A3 Cytoplasm

Most sorghum x sudangrass hybrids are currently produced in Al male-sterile cytoplasm. Availability of alternative cytoplasmic sterility systems allows production of sorghum x sudangrass hybrids that may have superior forage characteristics. A study was conducted to compare the agronomic performance of Al and A3 sorghum x sudangrass hybrids. A bulk of eight sudangrass populations was used to pollinate four grain sorghum inbreds normally used as females that had been sterilized in both Al and A3 cytoplasm, and two inbreds normally used as males that had been sterilized in A3 cytoplasm. The hybrids were evaluated in 1990. Results indicate that male-sterile sorghum x sudangrass hybrids can be made using A3 cytoplasm male-sterilized inbreds from the heterotic pool of inbreds normally used as pollinators. Additionally, the high level of fertility restoration by sudangrass in A3 cytoplasm male-sterilized sorghum normally used as females indicates that sudangrass may contribute much needed A3 restorers to the sorghum industry

Fertility and Forage Yield of Sorghum X Sudangrass Hybrids in A1 and A3 Cytoplasm

Most sorghum x sudangrass hybrids are currently produced in Al male-sterile cytoplasm. Availability of alternative cytoplasmic sterility systems allows production of sorghum x sudangrass hybrids that may have superior forage characteristics. A study was conducted to compare the agronomic performance of Al and A3 sorghum x sudangrass hybrids. A bulk of eight sudangrass populations was used to pollinate four grain sorghum inbreds normally used as females that had been sterilized in both Al and A3 cytoplasm, and two inbreds normally used as males that had been sterilized in A3 cytoplasm. The hybrids were evaluated in 1990. Results indicate that male-sterile sorghum x sudangrass hybrids can be made using A3 cytoplasm male-sterilized inbreds from the heterotic pool of inbreds normally used as pollinators. Additionally, the high level of fertility restoration by sudangrass in A3 cytoplasm male-sterilized sorghum normally used as females indicates that sudangrass may contribute much needed A3 restorers to the sorghum industry

Yield and Forage Value of a Dual-Purpose \u3ci\u3ebmr-12\u3c/i\u3e Sorghum Hybrid

Grain sorghum [Sorghum bicolor (L.) Moench] is an important crop for rainfed production systems with 2.7 million ha grown in the United States in 2013. The brown-midrib (bmr) mutations, especially bmr-12, have resulted in low stover lignin and high fiber digestibility without reducing grain yield in some sorghum lines. However, the effect of the bmr trait on beef cattle (Bos taurus) performance when grazing crop residue is unknown. Our objectives were to validate previous small-plot results reporting no grain yield difference between near-isogenic bmr-12 (BMR) and wild-type control (CON) A Wheatland × R Tx430 sorghum hybrids in a field-scale experiment and to determine if BMR stover enhances beef production in a grazing experiment. Four replicated paddocks (2.3 ha) were planted in 2006 and 2008 near Mead, NE. Crossbred yearling steers (240 ± 17 kg hd-1) grazed (2.6 steers ha-1) paddocks following grain harvest for 72 d in 2006 and 61 d in 2008. Forage was sampled 4, 30, and 60 d after grazing began. Grain yield of BMR was 6% less (P = 0.01) than CON with no difference in stover neutral detergent fiber (NDF) content, but BMR stover had higher in vitro NDF digestibility (IVNDFD) (31%; P \u3c 0.0001), steer average daily gain (ADG; 0.18 kg hd-1 d-1; P = 0.001), and body weight (BW) gain (29 kg ha-1; P = 0.002), resulting in an estimated increase in net return of $133.84 ha-1 due to BMR. Results suggest that the A Wheatland × R Tx430 bmr-12 hybrid is an effective dual-purpose sorghum crop for both grain and beef production

Registration of N619 to N640 Grain Sorghum Lines with Waxy or Wild-Type Endosperm

Sorghum [Sorghum bicolor (L.) Moench] lines N619 to N636 (A lines; Reg. No. GS-699 to GS-716, PI 670134 to PI 670151); N619 to N636 (B lines; Reg. No. GS-721 to GS-738, PI 671777 to PI 671794); and N637 to N640 (R lines; Reg. No. GS-717 to GS-720, PI 670152 to PI 670155) comprise nine pairs of seed parent (A/B) lines, and two pairs of pollinator (R) lines (11 pairs total) that are near-isogenic for waxy (low-amylose) or wildtype endosperm. Breeding work was conducted jointly by the USDA–ARS and the Agricultural Research Division, Institute of Agriculture and Natural Resources, University of Nebraska, and the lines were released in May 2014. Release of these lines makes available two different waxy (wx) alleles (wxa and wxb) for development of grain sorghum as a source of lowamylose starch, whose end use is targeted to the ethanol and food industries. In particular, the release of wx and wild-type near-isogenic pairs facilitates the evaluation of agronomic performance of wx genotypes, and the release of both A/B and R lines facilitates the production of waxy grain hybrids

Evaluation of Interallelic \u3ci\u3ewaxy\u3c/i\u3e, Hetero\u3ci\u3ewaxy\u3c/i\u3e, and Wild-Type Grain Sorghum Hybrids

Four near-isogenic Wheatland x Tx430 grain sorghum [Sorghum bicolor (L.) Moench] hybrids differing in allelic status at the Waxy locus were grown in yield trials to determine their potential to expand existing sources of low-amylose starch. The hypothesis tested was that agronomic performance and grain yield do not differ among hybrid genotypes. Hybrids were generated in a two-by-two factorial design using wxb and wild-type (WT) Wheatland as female parents with wxa and WT Tx430 as male parents. Yield trials were conducted at two Nebraska locations in 2009 and 2010. No differences were observed for field emergence, but grain yield of the interallelic waxy (wxb x wxa) hybrid was 330 kg ha−1 greater than the WT x WT hybrid (P = 0.0482). The wxb x Wx hybrid had the highest grain yield, 633 kg ha−1 greater than the WT (P = 0.0003). Amylose starch content was lowest for wxb x wxa (7.66 g kg−1), intermediate for wxb x Wx and Wx x wxa (25.06 and 27.20 g kg−1, respectively); and highest for WT x WT (34.80 g kg−1) (n = 4, P \u3c 0.0001). The waxy and heterowaxy hybrids evaluated in this study are promising options for commercial production of starches with reduced amylose contents in a drought-tolerant crop

Genetic analysis of seed traits in \u3ci\u3eSorghum bicolor\u3c/i\u3e that affect the human gut microbiome

Prebiotic fibers, polyphenols and other molecular components of food crops significantly affect the composition and function of the human gut microbiome and human health. The abundance of these, frequently uncharacterized, microbiome-active components vary within individual crop species. Here, we employ high throughput in vitro fermentations of pre-digested grain using a human microbiome to identify segregating genetic loci in a food crop, sorghum, that alter the composition and function of human gut microbes. Evaluating grain produced by 294 sorghum recombinant inbreds identifies 10 loci in the sorghum genome associated with variation in the abundance of microbial taxa and/or microbial metabolites. Two loci co-localize with sorghum genes regulating the biosynthesis of condensed tannins. We validate that condensed tannins stimulate the growth of microbes associated with these two loci. Our work illustrates the potential for genetic analysis to systematically discover and characterize molecular components of food crops that influence the human gut microbiome

Additional resource needs for viral hepatitis elimination through universal health coverage : projections in 67 low-income and middle-income countries, 2016–30

Background: The World Health Assembly calls for elimination of viral hepatitis as a public health threat by 2030 (ie, −90% incidence and −65% mortality). However, WHO's 2017 cost projections to achieve health-related Sustainable Development Goals did not include the resources needed for hepatitis testing and treatment. We aimed to estimate the incremental commodity cost of adding scaled up interventions for testing and treatment of hepatitis to WHO's investment scenarios. Methods: We added modelled costs for implementing WHO recommended hepatitis testing and treatment to the 2017 WHO cost projections. We quantified additional requirements for diagnostic tests, medicines, health workers' time, and programme support across 67 low-income and middle-income countries, from 2016–30. A progress scenario scaled up interventions and a more ambitious scenario was modelled to reach elimination by 2030. We used 2018 best available prices of diagnostics and generic medicines. We estimated total costs and the additional investment needed over the projection of the 2016 baseline cost. Findings: The 67 countries considered included 230 million people living with hepatitis B virus (HBV) and 52 million people living with hepatitis C virus (HCV; 90% and 73% of the world's total, respectively). Under the progress scenario, 3250 million people (2400 million for HBV and 850 million for HCV) would be tested and 58·2 million people (24·1 million for HBV and 34·1 million for HCV) would be treated (total additional cost US$27·1 billion). Under the ambitious scenario, 11 631 million people (5502 million for HBV and 6129 million for HCV) would be tested and 93·8 million people (32·2 million for HBV and 61·6 million for HCV) would be treated (total additional cost$58·7 billion), averting 4·5 million premature deaths and leading to a gain of 51·5 million healthy life-years by 2030. However, if affordable HCV medicines remained inaccessible in 13 countries where medicine patents are protected, the additional cost of the ambitious scenario would increase to $118 billion. Hepatitis elimination would account for a 1·5% increase to the WHO ambitious health-care strengthening scenario costs, avert an additional 4·6% premature deaths, and add an additional 9·6% healthy life-years from 2016–30. Interpretation: Access to affordable medicines in all countries will be key to reach hepatitis elimination. This study suggests that elimination is feasible in the context of universal health coverage. It points to commodities as key determinants for the overall price tag and to options for cost reduction strategies. Funding: WHO, United States Centers for Disease Control and Prevention, Unitaid